Guardion Health Sciences Inc.

1.84+0.1800+10.84%Vol 1.67M1Y Perf -25.06%
Apr 16th, 2021 16:00 DELAYED
BID1.85 ASK1.88
Open1.62 Previous Close1.66
Pre-Market- After-Market-
 - -  - -%
Target Price
- 
Analyst Rating
— — 0.00
Potential %
- 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★+     50.10
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Market Cap44.95M 
Earnings Rating
Neutral
Price Range Ratio 52W %
11.47 
Earnings Date
1st Apr 2021

Today's Price Range

1.541.90

52W Range

0.99008.40

Summary:

Sell

Technical Indicators: Sell
Moving Averages: Strong Sell
Performance
1 Week
-13.21%
1 Month
-32.35%
3 Months
-51.71%
6 Months
52.19%
1 Year
-25.06%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
GHSI1.840.180010.84
AAPL134.16-0.3400-0.25
GOOG2 297.761.10000.05
MSFT260.741.24000.48
XOM56.66-0.3200-0.56
WFC43.841.60003.79
JNJ162.241.85001.15
FB306.18-1.6400-0.53
GE13.39-0.1600-1.18
JPM153.301.13000.74
Financial StrengthValueIndustryS&P 500US Markets
7.90
8.50
0.03
0.05
-1 177.90
Leverage Ratio 1.10
ProfitabilityValueIndustryS&P 500US Markets
-3.30
-479.40
-454.30
-1 554.40
-
RevenueValueIndustryS&P 500US Markets
1.64M
0.07
42.33
63.89
Earnings HistoryEstimateReportedSurprise %
Q03 2020--0.02-
Q02 2020--0.01-
Q03 2019--0.07-
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date-
Estimated EPS Next Report-
Estimates Count-
EPS Growth Next 5 Years %-
Volume Overview
Volume1.67M
Shares Outstanding24.43M
Trades Count5.71K
Dollar Volume17.00M
Avg. Volume4.34M
Avg. Weekly Volume1.26M
Avg. Monthly Volume1.23M
Avg. Quarterly Volume3.54M

Guardion Health Sciences Inc. (NASDAQ: GHSI) stock closed at 1.84 per share at the end of the most recent trading day (a 10.84% change compared to the prior day closing price) with a volume of 1.68M shares and market capitalization of 44.95M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Drug Manufacturers industry, Healthcare sector and employs 22 people. Guardion Health Sciences Inc. CEO is Bret Scholtes.

The one-year performance of Guardion Health Sciences Inc. stock is -25.06%, while year-to-date (YTD) performance is -26.1%. GHSI stock has a five-year performance of %. Its 52-week range is between 0.99 and 8.4, which gives GHSI stock a 52-week price range ratio of 11.47%

Guardion Health Sciences Inc. currently has a PE ratio of -0.60, a price-to-book (PB) ratio of 6.08, a price-to-sale (PS) ratio of 27.63, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -71.79%, a ROC of -93.43% and a ROE of -79.31%. The company’s profit margin is -%, its EBITDA margin is -454.30%, and its revenue ttm is $1.64 Million , which makes it $0.07 revenue per share.

Of the last four earnings reports from Guardion Health Sciences Inc., there were 0 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.00 for the next earnings report. Guardion Health Sciences Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Guardion Health Sciences Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for Guardion Health Sciences Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Guardion Health Sciences Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Guardion Health Sciences Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 53.34, ATR14 : 0.32, CCI20 : -115.53, Chaikin Money Flow : -0.03, MACD : 0.26, Money Flow Index : 31.22, ROC : -24.28, RSI : 61.59, STOCH (14,3) : 27.52, STOCH RSI : 0.24, UO : 40.73, Williams %R : -72.48), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Guardion Health Sciences Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

Guardion Health Sciences Inc.

Guardion Health Sciences Inc is a specialty health sciences company formed to develop, formulate and distribute condition-specific medical foods with an initial medical food product. The company's Lumega-Z, is a micronized lipid-base nutritional formulation designed to restore and maintain the condition of a depleted macular pigment. It has also developed GlaucoCetin, the first regulated vision-specific Medical Food designed to support and protect the mitochondrial function of optic nerve cells in patients with glaucoma.

CEO: Bret Scholtes

Telephone: +1 858 605-9055

Address: 15150 Avenue of Science, San Diego 92128, CA, US

Number of employees: 22

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

49%51%

Bearish Bullish

51%49%

Bearish Bullish

53%47%

News

Stocktwits